OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
000818$16.7556

Hangjin Technology Co Ltd

Commodity ChemicalsVerified

Hangjin Technology Co Ltd operates with a debt-to-equity ratio of 2.18, indicating a capital structure that is significantly leveraged. The company's liquidity position is assessed as medium, with a current ratio of 0.95, suggesting limited short-term liquidity cushion. The price-to-book ratio of 5.16 implies that the market values the company at a premium to its book value, despite its negative net income of -153,094,490 CNY. Profitability metrics are weak, with a return on equity of -7.15% and a return on assets of -1.88%, both significantly below the industry norms for commodity chemicals. The company's operating income is negative at -76,599,910 CNY, and its gross profit margin is 14.2%, which is below the median for its industry. These figures suggest that the company is struggling to generate sustainable earnings from its core operations. The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification in the latest financials. This lack of diversification increases exposure to regional economic fluctuations and regulatory changes in China. The company's revenue of 4,123,169,810 CNY is below the analyst estimate of 3,536,491,590 CNY, indicating a potential overstatement or a recent revenue boost. Looking ahead, the company's growth trajectory is uncertain. The current fiscal year is expected to show a decline in revenue, with no clear indication of a turnaround in the next fiscal year. The company's capital expenditure of -35,558,020 CNY suggests a reduction in investment, which may signal a defensive strategy or financial constraints. The company faces several risk factors, including a negative net cash position after subtracting total debt, which raises concerns about its ability to meet short-term obligations. The risk of dilution is assessed as low, with no significant changes in shares outstanding between basic and diluted shares. However, the company's negative operating income and weak profitability metrics suggest a need for close monitoring of its financial health. Recent events include the latest financial filing, which shows a significant drop in operating income and net income. The company has not disclosed any major strategic initiatives or capital raising activities in the latest reports, which may indicate a period of operational or financial stress.

30-day price · 000818(missing data)
No daily-bar history available from current data sources. Alternate source pending.
Profile
CompanyHangjin Technology Co Ltd
Ticker000818.SZ
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustryCommodity Chemicals
AI analysis

Business. Hangjin Technology Co Ltd is a Chinese chemical manufacturing company that produces and sells commodity chemicals, primarily serving industrial and manufacturing sectors.

Classification. The company is classified under the Basic Materials economic sector, Chemicals business sector, and Commodity Chemicals industry, with a classification confidence of 0.92 based on verified market data.

Hangjin Technology Co Ltd operates with a debt-to-equity ratio of 2.18, indicating a capital structure that is significantly leveraged. The company's liquidity position is assessed as medium, with a current ratio of 0.95, suggesting limited short-term liquidity cushion. The price-to-book ratio of 5.16 implies that the market values the company at a premium to its book value, despite its negative net income of -153,094,490 CNY. Profitability metrics are weak, with a return on equity of -7.15% and a return on assets of -1.88%, both significantly below the industry norms for commodity chemicals. The company's operating income is negative at -76,599,910 CNY, and its gross profit margin is 14.2%, which is below the median for its industry. These figures suggest that the company is struggling to generate sustainable earnings from its core operations. The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification in the latest financials. This lack of diversification increases exposure to regional economic fluctuations and regulatory changes in China. The company's revenue of 4,123,169,810 CNY is below the analyst estimate of 3,536,491,590 CNY, indicating a potential overstatement or a recent revenue boost. Looking ahead, the company's growth trajectory is uncertain. The current fiscal year is expected to show a decline in revenue, with no clear indication of a turnaround in the next fiscal year. The company's capital expenditure of -35,558,020 CNY suggests a reduction in investment, which may signal a defensive strategy or financial constraints. The company faces several risk factors, including a negative net cash position after subtracting total debt, which raises concerns about its ability to meet short-term obligations. The risk of dilution is assessed as low, with no significant changes in shares outstanding between basic and diluted shares. However, the company's negative operating income and weak profitability metrics suggest a need for close monitoring of its financial health. Recent events include the latest financial filing, which shows a significant drop in operating income and net income. The company has not disclosed any major strategic initiatives or capital raising activities in the latest reports, which may indicate a period of operational or financial stress.
Key takeaways
  • The company is highly leveraged with a debt-to-equity ratio of 2.18, indicating a capital structure that is significantly debt-dependent.
  • Profitability is weak, with a return on equity of -7.15% and a return on assets of -1.88%, both below industry norms.
  • The company's revenue is concentrated in a single business segment, increasing exposure to regional economic and regulatory risks.
  • The company's liquidity position is assessed as medium, with a current ratio of 0.95, suggesting limited short-term liquidity cushion.
  • The company's growth trajectory is uncertain, with no clear indication of a turnaround in the next fiscal year.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyCNY
Revenue$4.12B
Gross profit$585.4M
Operating income-$76.6M
Net income-$153.1M
R&D
SG&A
D&A
SBC
Operating cash flow$786.0M
CapEx-$35.6M
Free cash flow$226.6M
Total assets$8.13B
Total liabilities$5.99B
Total equity$2.14B
Cash & equivalents
Long-term debt$4.67B
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0$4.12B-$76.6M-$153.1M$226.6M
FY-1$4.17B-$947.5M-$979.1M-$2.74B
FY-2$3.67B$150.4M$128.1M-$23.4M
FY-3$4.29B$231.1M$229.8M$238.0M
FY-4$4.86B$828.8M$732.3M$656.3M
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0$8.13B$2.14B
FY-1$8.54B$2.29B
FY-2$6.01B$3.70B
FY-3$5.12B$3.61B
FY-4$5.25B$3.45B
PeriodOCFCapExFCFSBC
FY0$786.0M-$35.6M$226.6M
FY-1-$92.7M-$1.93B-$2.74B
FY-2-$88.7M-$261.4M-$23.4M
FY-3$224.2M-$64.9M$238.0M
FY-4$722.2M-$38.2M$656.3M
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0$740.1M$35.1M$16.2M
FQ-1$836.6M-$179.9M-$168.3M
FQ-2$1.07B$14.3M$1.5M
FQ-3$1.15B$44.0M$8.6M
FQ-4$1.07B$47.7M$5.2M
FQ-5$930.0M-$1.06B-$1.02B
FQ-6$1.15B$48.3M$7.8M
FQ-7$467.1M-$19.3M-$17.6M
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0$7.49B$2.19B$697.5M
FQ-1$8.13B$2.14B
FQ-2$8.62B$2.31B$757.6M
FQ-3$8.58B$2.31B
FQ-4$8.42B$2.30B$1.12B
FQ-5$8.54B$2.29B
FQ-6$9.73B$3.37B$1.41B
FQ-7$8.23B$3.56B
PeriodOCFCapExFCFSBC
FQ0$162.4M-$429.2k
FQ-1$786.0M-$35.6M
FQ-2$781.0M-$848.2M
FQ-3$379.5M-$841.2M
FQ-4$147.2M-$95.2M
FQ-5-$92.7M-$1.93B
FQ-6-$57.0M-$1.39B
FQ-7-$9.3M-$1.35B
Valuation
Market price$16.75
Market cap$11.06B
Enterprise value$15.72B
P/E
Reported non-GAAP P/E
EV/Revenue3.8
EV/Op income
EV/OCF20.0
P/B5.2
P/Tangible book5.2
Tangible book$2.14B
Net cash-$4.67B
Current ratio0.9
Debt/Equity2.2
ROA-1.9%
ROE-7.1%
Cash conversion-5.1%
CapEx/Revenue-0.9%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Chemicals · cohort 11 companies
Metric000818Activity
Op margin-1.9%0.4% medp25 -8.0% · p75 16.0%below median
Net margin-3.7%2.3% medp25 -11.6% · p75 11.8%below median
Gross margin14.2%20.8% medp25 14.9% · p75 24.0%bottom quartile
R&D / revenue1.1% medp25 0.5% · p75 1.3%
CapEx / revenue-0.9%6.2% medp25 5.4% · p75 10.2%bottom quartile
Debt / equity218.0%59.0% medp25 54.9% · p75 72.9%top quartile
Observations
IR observations
Last actual revenue3,536,491,590 CNY
Source: analysis-pipeline (hybrid)Generated: 2026-05-17 03:46 UTCJob: 7b90226d